MENU
AKRO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Akero Therapeutics (AKRO) Ownership - Who owns Akero Therapeutics?
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs... Show more
Profile
Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 487-6488
Employees
56
Web
https://www.akerotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.95B
P/E Ratio
N/A
Total Cash
686.29M
Projected Growth
N/A
Total Debt
36.57M
Revenue
N/A
Risk (Beta)
-1.22
Dividend Yield
N/A
Total Cash/Share
8.61
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AKRO
Capitalization
3.95B
P/E Ratio
N/A
Risk (Beta)
-1.22
Dividend Yield
N/A
Total Cash
686M
Total Cash/Share
8.61
Total Debt
36.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.08B
P/B Ratio
3.58
Cash Flow
N/A
Earnings
-3.75
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
16.80
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-264.59M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-26.06
Shares Held By Institutions
5.6B
Shares Outstanding - Current
79.7M
Total Liabilities
72M
Total Volume MTD
N/A
Value
N/A
Gain YTD
78.145
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology company, which specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 487-6488
Employees
56
Web
https://www.akerotx.com